Icon (ICLR) Competitors $171.76 +0.01 (+0.01%) Closing price 04:00 PM EasternExtended Trading$171.79 +0.03 (+0.02%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICLR vs. MEDP, CRL, IQV, TMO, WCN, RDDT, TCOM, CPAY, TOST, and RBAShould you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Thermo Fisher Scientific (TMO), Waste Connections (WCN), Reddit (RDDT), Trip.com Group (TCOM), Corpay (CPAY), Toast (TOST), and RB Global (RBA). Icon vs. Its Competitors Medpace Charles River Laboratories International IQVIA Thermo Fisher Scientific Waste Connections Reddit Trip.com Group Corpay Toast RB Global Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation. Do insiders and institutionals believe in MEDP or ICLR? 78.0% of Medpace shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 44.0% of Icon shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend MEDP or ICLR? Medpace presently has a consensus target price of $406.60, suggesting a potential downside of 13.36%. Icon has a consensus target price of $218.38, suggesting a potential upside of 27.15%. Given Icon's stronger consensus rating and higher possible upside, analysts clearly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 9 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93Icon 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 2.75 Which has preferable earnings & valuation, MEDP or ICLR? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B6.25$404.39M$13.4534.89Icon$8.09B1.71$791.47M$9.7217.67 Does the media favor MEDP or ICLR? In the previous week, Medpace had 15 more articles in the media than Icon. MarketBeat recorded 21 mentions for Medpace and 6 mentions for Icon. Medpace's average media sentiment score of 1.33 beat Icon's score of 0.19 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 17 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is MEDP or ICLR more profitable? Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Icon 9.82%10.95%6.23% Which has more volatility & risk, MEDP or ICLR? Medpace has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Icon News Delivered to You Automatically Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICLR vs. The Competition Export to ExcelMetricIconMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.87B$7.69B$5.74B$9.77BDividend YieldN/A2.69%4.40%4.08%P/E Ratio17.6778.4130.4126.04Price / Sales1.7149.61428.97104.72Price / Cash8.7725.5525.7828.79Price / Book1.467.619.706.08Net Income$791.47M$242.04M$3.27B$265.64M7 Day Performance-4.39%0.02%3.94%3.11%1 Month Performance-8.15%-0.71%3.81%0.39%1 Year Performance-46.82%8.50%31.26%18.52% Icon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICLRIcon4.5983 of 5 stars$171.76+0.0%$218.38+27.1%-47.0%$13.87B$8.09B17.6741,900MEDPMedpace4.3105 of 5 stars$462.91+1.1%$406.60-12.2%+19.4%$12.86B$2.11B34.425,900Positive NewsCRLCharles River Laboratories International4.1652 of 5 stars$157.27+0.4%$175.69+11.7%-20.1%$7.71B$4.05B-118.2520,100Positive NewsIQVIQVIA4.896 of 5 stars$192.58+0.8%$228.62+18.7%-24.4%$32.49B$15.41B27.8788,000Positive NewsTMOThermo Fisher Scientific4.9586 of 5 stars$488.15-0.2%$593.00+21.5%-19.0%$184.66B$42.88B28.23125,000Positive NewsWCNWaste Connections4.6465 of 5 stars$184.88+0.1%$215.00+16.3%-2.2%$47.74B$8.92B74.5523,854RDDTReddit3.0026 of 5 stars$241.76-1.9%$171.83-28.9%+271.5%$46.13B$1.30B219.782,233TCOMTrip.com Group4.1565 of 5 stars$62.95+0.9%$77.25+22.7%+56.3%$40.74B$7.30B18.2541,073Positive NewsUpcoming EarningsCPAYCorpay3.7387 of 5 stars$316.90-0.2%$396.33+25.1%+8.3%$22.43B$3.97B21.5311,200Positive NewsTOSTToast3.267 of 5 stars$42.47-1.6%$45.54+7.2%+83.4%$22.01B$4.96B124.915,700Positive NewsRBARB Global3.8834 of 5 stars$115.31+0.4%$119.79+3.9%+34.4%$21.32B$4.28B57.087,800Positive News Related Companies and Tools Related Companies MEDP Alternatives CRL Alternatives IQV Alternatives TMO Alternatives WCN Alternatives RDDT Alternatives TCOM Alternatives CPAY Alternatives TOST Alternatives RBA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICLR) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access